文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Lloyd Haskell
发表
Healthcare Cost Impact of Continued Anticoagulation with Rivaroxaban versus Aspirin for Prevention of Recurrent Symptomatic Venous Thromboembolism in the EINSTEIN-CHOICE Trial Population Continued Anticoagulation with Rivaroxaban for Prevention of Recurrent Symptomatic Venous Thromboembolism in
B. Levitan, F. Laliberté, C. Crivera, 2018 .
Healthcare Cost Impact of Continued Anticoagulation with Rivaroxaban versus Aspirin for Prevention of Recurrent Symptomatic Venous Thromboembolism in the EINSTEIN-CHOICE Trial Population
M. Prins, Yongling Xiao, P. Prandoni, 2018 .